Construction of eukaryotic recombinant sTRAIL expression vector and Its effect on C6 glioma xenograft in athymic mice

李谷,马力,温良,龚江标,杨小锋,詹仁雅
DOI: https://doi.org/10.3969/j.issn.1006-2785.2008.04.008
2008-01-01
Abstract:Objective To construct eukaryotic recombinant sTRAIL expression vector and to investigate its effect on C6 glioma xenograft in athymic mice. Methods Eukaryotic recombinant sTRAIL expression vector PcDNA-sTRAIL was constructed by means of PCR and directed cloning. PcDNA-sTRAIL was transfected to C6 glioma cells mediated by cationic liposome and the positive transfection rate was detected by immunohistochemistry. C6 glioma xenografts in athymic mice were treated with PcDNA-sTRAIL plus lipofectin or blank vector and lipofectin as control groups. The weight and volume of xenografts in each groups were compared. Results The construction of eukaryotic recombinant sTRAIL expression vector PcDNA-sTRAIL was confirmed by gene sequencing and Western blot. After transfection of PcDNA-sTRAIL, up to 50 % of C6 cells positively expressed sTRAIL protein. In the in vivo study, both weight and volume in PcDNA-sTRAIL plus Lipofectin group were significantly lower than those in control groups (P<0.01). Conclusion A eukaryotic recombinant sTRAIL expression vector was successfully constructed and it can inhibit the growth of C6 glioma xenograft in athymic mice.
What problem does this paper attempt to address?